Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI scores Centene Corp every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Centene Corp is a large-cap company with a market capitalization of $34.53B. It ranks number 5 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its P/B Ratio of 1.55x is the lowest of the 10 peers that report one.
For CNC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 69.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 36.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CNC included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
| Metric | CNC | Rank |
|---|---|---|
| Market Cap | $34.53B | 5/10 |
| P/E Ratio | 23.17x | 3/7 |
| P/B Ratio | 1.55x | 10/10 |
| EPS | $3.01 | – |
| Book Value/Share | $44.86 | – |
| Revenue/Share | $411.85 | – |
| FCF/Share | $7.96 | – |
| Metric | CNC | Rank |
|---|---|---|
| ROE | 6.6% | 7/7 |
| ROA | 1.8% | 7/7 |
| ROIC | 2.5% | 9/10 |
| Gross Margin | 98.6% | 1/6 |
| Operating Margin | 0.5% | 8/10 |
| Net Margin | 0.7% | 7/7 |
| EBT Margin | 0.9% | 7/10 |
| Tax Rate | 23.9% | – |
| Metric | CNC | Rank |
|---|---|---|
| Current Ratio | 1.16x | 7/10 |
| D/E Ratio | 2.57x | 5/10 |
| Financial Leverage | 3.57x | 5/10 |
| Working Capital | $6.39B | 3/10 |
| Metric | CNC | Rank |
|---|---|---|
| Operating Cash Flow | $4.72B | 4/10 |
| Free Cash Flow | $3.94B | 4/9 |
| Capital Spending | -$781M | 7/9 |
| OCF Growth YoY | 16.2% | 5/8 |
| FCF Growth YoY | 17.5% | 6/7 |
| FCF/Sales | 1.9% | 7/9 |
| CapEx/Sales | 0.4% | 5/9 |
| Metric | CNC | Rank |
|---|---|---|
| Asset Turnover | 2.57x | 5/10 |
| Fixed Assets Turnover | 96.7x | 4/10 |
| Metric | CNC | Rank |
|---|---|---|
| Total Revenue | $203.90B | 3/10 |
| Operating Income | $1.01B | 5/10 |
| Net Income | $1.46B | 4/7 |
| SG&A Expense | $13.11B | 5/8 |
| Cost of Goods Sold | $2.79B | 5/6 |
| Metric | CNC | Rank |
|---|---|---|
| Shares Outstanding | 495M | – |
| Total Current Assets | $45.46B | 57.3% of assets |
| Cash & Short-term Investments | $20.70B | 26.1% of assets |
| Total Liabilities | $56.97B | 71.9% of assets |
Companies classified under the same SEC industry code as Centene Corp (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CNC Centene Corp | $34.53B | |
| UNH Unitedhealth Group Inc | $353.79B | |
| ELV Elevance Health, Inc. | $91.96B | |
| CI Cigna Group | $77.58B | |
| HUM Humana Inc | $52.17B | |
| MOH Molina Healthcare, Inc. | $11.31B | |
| OSCR Oscar Health, Inc. | $9.46B | |
| CLOV Clover Health Investments, Corp. /De | $2.56B | |
| TRUP Trupanion, Inc. | $1.61B | |
| ALHC Alignment Healthcare, Inc. | $1.54B |
Shares of Centene Corp. surged 12.64% to $76.01 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.58% to 7,688.62 and the Dow ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Shares of Centene Corporation (NYSE: CNC) traded at a new 52-week high today and are currently trading at $72.24. So far ...
Our AI scores Centene Corp every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For CNC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 69.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 36.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Centene Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
10 issuers in our coverage, CNC included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Cigna Group (CI), Humana Inc (HUM), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
